I. Laszlovszky
Gedeon Richter (Hungary)(HU)
Publications by Year
Research Areas
Schizophrenia research and treatment, Bipolar Disorder and Treatment, Neurotransmitter Receptor Influence on Behavior, Treatment of Major Depression, Receptor Mechanisms and Signaling
Most-Cited Works
- → Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile(2010)360 cited
- → Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial(2017)338 cited
- → An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression(2015)203 cited
- → An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial(2014)189 cited
- → Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia(2015)176 cited
- → Cariprazine in Acute Exacerbation of Schizophrenia(2015)165 cited
- → Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats(2004)127 cited
- → The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial(2014)126 cited
- → Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO(2016)124 cited
- → Cariprazine in the treatment of acute mania in bipolar I disorder: A double-blind, placebo-controlled, Phase III trial(2014)123 cited